cyc 202 has been researched along with Heart Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalifour, LE; Marcantonio, D; Servant, N; Th'ng, JP | 1 |
1 other study(ies) available for cyc 202 and Heart Diseases
| Article | Year |
|---|---|
TBP-associated factor 1 overexpression induces tolerance to Doxorubicin in confluent H9c2 cells by an increase in cdk2 activity and cyclin E expression.
Topics: Animals; Antibiotics, Antineoplastic; Carrier Proteins; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Line; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Doxorubicin; Drug Tolerance; Enzyme Inhibitors; Gene Expression Regulation; Genes, Dominant; Heart Diseases; Histone Acetyltransferases; Intracellular Signaling Peptides and Proteins; Mutation; Myocytes, Cardiac; Protein Structure, Tertiary; Purines; Rats; Recombinant Proteins; Roscovitine; Signal Transduction; TATA-Binding Protein Associated Factors; Transcription Factor TFIID | 2004 |